NKT3447

· NiKang Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NKT3447, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]